Insider Transactions Reported by 20 Insiders of Entrada Therapeutics, Inc.

Symbol
TRDA on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Entrada Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
L.P. MPM BioVentures 2014 10%+ Owner $88,628,884 10 Dec 2024
MPM BIOVENTURES 2018, L.P. 10%+ Owner $88,628,884 10 Dec 2024
ROCHE HOLDING LTD 10%+ Owner $44,988,265 02 Nov 2021
BAKER BROS. ADVISORS LP 10%+ Owner $42,564,061 +$1,614,433 +3.9% 20 Nov 2025
Kush Parmar Director, 10%+ Owner $32,831,654 -$2,829,187 -7.9% 14 Nov 2025
5AM Ventures V, L.P. 10%+ Owner $32,831,654 -$2,829,187 -7.9% 14 Nov 2025
Redmile Group, LLC 10%+ Owner $31,251,176 02 Nov 2021
Dipal Doshi CEO, Director $6,184,030 01 Mar 2026
Natarajan Sethuraman President, Research & Develop. $2,847,682 01 Mar 2026
Nathan J. Dowden President & COO $2,511,143 01 Mar 2026
PETER S. KIM Director $1,712,677 11 Jun 2025
KORY JAMES WENTWORTH Chief Financial Officer $1,691,016 -$205,859 -11% 04 Mar 2026
Nerissa Kreher Chief Medical Officer $640,192 01 Sep 2023
Todd Foley Director, 10%+ Owner 02 Jun 2022
John F. Crowley Director 08 Jun 2023
Maha Radhakrishnan Director 01 Jun 2025
Bernhardt Zeiher Director 11 Jun 2025
Mary Thistle Director 11 Jun 2025
Gina Chapman Director 11 Jun 2025
Carole Nuechterlein Director 02 Jun 2022

Recent Insider Transactions by Companies or Individuals for Entrada Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.